Suppr超能文献

阿尔茨海默病中淀粉样β蛋白在脑组织以外的组织中的沉积。

Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.

作者信息

Joachim C L, Mori H, Selkoe D J

机构信息

Department of Neurology, Harvard Medical School, Boston, Massachusetts.

出版信息

Nature. 1989 Sep 21;341(6239):226-30. doi: 10.1038/341226a0.

Abstract

Alzheimer's disease is the most common cause of progressive intellectual failure in aged humans. The filamentous brain lesions which define the disease occur within neurons (neurofibrillary tangles), in extracellular cerebral deposits (amyloid plaques) and in meningocerebral blood vessels (amyloid angiopathy). They are found in lesser numbers in the brains of virtually all old humans. A protein with a relative molecular mass (Mr) of approximately 4,000, designated amyloid beta-protein or amyloid A4 protein, is the subunit of the vascular and plaque amyloid filaments in individuals with Alzheimer's disease, normal ageing and trisomy 21 (Down's syndrome). The amyloid beta-protein is a small fragment of a membrane-associated glycoprotein, encoded by a gene on human chromosome 21 which is telomeric to a genetic defect that causes at least some cases of familial Alzheimer's disease. Until now, the pathological lesions of the disease have been found only in the brain, although reports of phenotypic abnormalities in non-neural tissues have suggested that Alzheimer's disease may be a widespread, systemic disorder. Here we report the detection of amyloid beta-protein deposits in non-neural tissues and blood vessels of Alzheimer's disease patients, including skin, subcutaneous tissue and intestine. The protein was also present in non-neural tissues in a proportion of aged, normal subjects. Our findings indicate that a principal feature of the disease process is expressed subclinically in tissues other than brain. The occurrence of amyloid beta-protein deposits in multiple tissues suggests that the protein may be produced locally in numerous organs or may, as in other human amyloidoses, be derived from a common circulating precursor. These observations affect the rationale for many experiments analysing the amyloid beta-protein precursor and its messenger RNAs in Alzheimer's disease brain tissue and have major implications for the pathogenesis and treatment of the disease.

摘要

阿尔茨海默病是老年人进行性智力衰退最常见的病因。界定该病的丝状脑损伤出现在神经元内(神经原纤维缠结)、细胞外脑沉积物中(淀粉样斑块)以及脑膜脑血管中(淀粉样血管病)。在几乎所有老年人的大脑中都能发现数量较少的这些损伤。一种相对分子质量(Mr)约为4000的蛋白质,称为β-淀粉样蛋白或A4淀粉样蛋白,是患有阿尔茨海默病、正常衰老和21三体综合征(唐氏综合征)个体中血管和斑块淀粉样纤维的亚基。β-淀粉样蛋白是一种膜相关糖蛋白的小片段,由人类21号染色体上的一个基因编码,该基因位于导致至少部分家族性阿尔茨海默病的遗传缺陷的端粒位置。到目前为止,该病的病理损伤仅在大脑中被发现,尽管有关于非神经组织表型异常的报道表明阿尔茨海默病可能是一种广泛的全身性疾病。在此我们报告在阿尔茨海默病患者的非神经组织和血管中检测到β-淀粉样蛋白沉积物,包括皮肤、皮下组织和肠道。在一部分老年正常受试者的非神经组织中也存在这种蛋白质。我们的研究结果表明,疾病过程的一个主要特征在大脑以外的组织中以亚临床形式表现出来。β-淀粉样蛋白沉积物在多种组织中的出现表明该蛋白质可能在许多器官中局部产生,或者可能像在其他人类淀粉样变性中一样,源自一种共同的循环前体。这些观察结果影响了许多分析阿尔茨海默病脑组织中β-淀粉样蛋白前体及其信使RNA的实验的理论基础,并对该病的发病机制和治疗具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验